Insmed Inc Stock Total Debt
| INSM Stock | USD 25.02 0.08 0.32% |
Insmed Inc fundamentals help investors to digest information that contributes to Insmed's financial success or failures. It also enables traders to predict the movement of Insmed Stock. The fundamental analysis module provides a way to measure Insmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insmed stock.
As of the 1st of December 2023, Total Debt is likely to grow to about 1.4 B. Insmed | Total Debt |
Insmed Total Debt Analysis
Insmed's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
More About Total Debt | All Equity Analysis
Insmed Total Debt |
|
Total Debt | = | Bonds | + | Notes |
Current Insmed Total Debt | 1.18 B |
Most of Insmed's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insmed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Insmed Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Insmed is extremely important. It helps to project a fair market value of Insmed Stock properly, considering its historical fundamentals such as Total Debt. Since Insmed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insmed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insmed's interrelated accounts and indicators.
Click cells to compare fundamentals
Insmed Total Debt Historical Pattern
Today, most investors in Insmed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Insmed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Insmed total debt as a starting point in their analysis.
Insmed Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Insmed Inc has a Total Debt of 1.18 B. This is 57.19% lower than that of the Biotechnology sector and 262.66% higher than that of the Health Care industry. The total debt for all United States stocks is 77.85% higher than that of the company.
Insmed Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insmed's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insmed could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics of similar companies.Insmed is currently under evaluation in total debt category among related companies.
Insmed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Insmed from analyzing Insmed's financial statements. These drivers represent accounts that assess Insmed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Insmed's important valuation drivers and their relationship over time.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||
| Net Income Per Employee | (869.4K) | (584.7K) | (562.9K) | (709.1K) | (654.3K) | (705.9K) | |
| Average Assets | 690.9M | 726.0M | 799.7M | 1.1B | 1.2B | 1.3B | |
| Earnings Before Interest Taxes and Depreciation Amortization EBITDA | (293.8M) | (205.9M) | (243.0M) | (369.2M) | (431.4M) | (442.8M) | |
| Earnings Before Interest Taxes and Depreciation Amortization USD | (293.8M) | (205.9M) | (243.0M) | (369.2M) | (431.4M) | (442.8M) | |
| Earnings before Tax | (324.1M) | (253.6M) | (292.7M) | (436.4M) | (480.2M) | (492.8M) | |
| Average Equity | 326.3M | 266.6M | 311.2M | 412.0M | 55.5M | 57.0M | |
| Enterprise Value | 755.7M | 2.0B | 3.2B | 3.0B | 3.1B | 2.5B | |
| Free Cash Flow | (271.1M) | (292.9M) | (225.6M) | (370.6M) | (410.3M) | (421.1M) | |
| Invested Capital | 287.6M | 513.0M | 500.2M | 793.9M | 1.5B | 1.6B | |
| Invested Capital Average | 320.5M | 448.3M | 513.2M | 711.5M | 1.2B | 1.3B | |
| Market Capitalization | 1.0B | 2.1B | 3.4B | 3.2B | 2.7B | 2.4B | |
| Tangible Asset Value | 545.9M | 688.6M | 746.9M | 1.0B | 1.5B | 1.6B | |
| Working Capital | 439.2M | 470.0M | 504.1M | 701.9M | 1.1B | 1.2B |
Insmed Institutional Holders
Institutional Holdings refers to the ownership stake in Insmed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Insmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Insmed's value.| Last Transaction | Type | Shares | Value | Absolute Investment Advisers Llc | 2023-09-30 | Debt | 8.7 M | 8.6 B | Vanguard Group Inc | 2023-09-30 | Common Shares | 14.3 M | 362.2 M | Price T Rowe Associates Inc | 2023-09-30 | Common Shares | 10.4 M | 262.8 M | Blackrock Inc | 2023-09-30 | Common Shares | 10.4 M | 262.4 M | T Rowe Price Investment Management Inc | 2023-09-30 | Common Shares | 8.3 M | 210.2 M | Deep Track Capital Lp | 2023-09-30 | Common Shares | 6 M | 151.5 M | Palo Alto Investors Lp | 2023-09-30 | Common Shares | 5.9 M | 148.7 M | State Street Corp | 2023-09-30 | Common Shares | 5.1 M | 127.6 M | Macquarie Group Ltd | 2023-09-30 | Common Shares | 4.7 M | 117.5 M | Fmr Llc | 2023-09-30 | Common Shares | 4.3 M | 108.7 M | Deerfield Management Company Lp Series C | 2023-09-30 | Debt | 108.9 M | 107.6 M |
Insmed Fundamentals
| Return On Equity | -14.53 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (2.58) % | ||||
| Operating Margin | (1.75) % | ||||
| Current Valuation | 3.97 B | ||||
| Shares Outstanding | 143.06 M | ||||
| Shares Owned By Insiders | 1.29 % | ||||
| Shares Owned By Institutions | 98.71 % | ||||
| Number Of Shares Shorted | 14.17 M | ||||
| Price To Earning | (8.70) X | ||||
| Price To Book | 48.18 X | ||||
| Price To Sales | 10.89 X | ||||
| Revenue | 245.36 M | ||||
| Gross Profit | 190.23 M | ||||
| EBITDA | (458.21 M) | ||||
| Net Income | (481.53 M) | ||||
| Cash And Equivalents | 554.87 M | ||||
| Cash Per Share | 4.62 X | ||||
| Total Debt | 1.18 B | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (2.02) X | ||||
| Cash Flow From Operations | (400.44 M) | ||||
| Short Ratio | 10.72 X | ||||
| Earnings Per Share | (5.29) X | ||||
| Target Price | 41.42 | ||||
| Number Of Employees | 736 | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 3.59 B | ||||
| Total Asset | 1.66 B | ||||
| Retained Earnings | (2.7 B) | ||||
| Working Capital | 1.08 B | ||||
| Current Asset | 28.15 M | ||||
| Current Liabilities | 3.89 M | ||||
| Z Score | -0.43 | ||||
| Annual Yield | 0.014 % | ||||
| Net Asset | 1.66 B |
About Insmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for 2023 | ||
| Total Debt | 1.3 B | 1.4 B |
Insmed Investors Sentiment
The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insmed Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Insmed Piotroski F Score and Insmed Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.29) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.167 | Return On Assets (0.36) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.